Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 02.11.2026 1 Am Heart J 1 Am J Clin Nutr 1 Am J Med 2 Am J Ophthalmol 4 BMC Ophthalmol 7 Diabet Med 3 Diabetes 4 Diabetes Care 13 Diabetes Obes Metab 6 Diabetologia 1 Invest Ophthalmol Vis Sci 2 J Clin Endocrinol Metab 1 J Immunol 2 JAMA 1 Metabolism 1 Ophthalmology 1 PLoS Genet 10 PLoS One 1 Proc Natl Acad Sci U S A 2 Retina 1 Transplant Proc 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. WITTKOPP S, Asachi P, Kazatsker F, Barua S, et al
   Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.
   Am Heart J. 2027;303:107573.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

2. REYNOLDS AN, Hood F, Iosua E, Shahin A, et al
   Impact of minimally processed versus milled whole grains on glycaemic control in type 2 diabetes: A 12-week randomised trial.
   Am J Clin Nutr. 2026 Oct 26:101601. doi: 10.1016/j.ajcnut.2026.101601.
   PubMed         Abstract available
   
   

   
   Am J Med

3. BANGA A, Deedwania P
   Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease and Type 2 Diabetes: A Narrative Review.
   Am J Med. 2026 Oct 30:S0002-9343(26)00773-4. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

4. WANG W, Qiu S
   Comment on "Evaluation of the impact of gamma-aminobutyric acid on diabetic retinopathy in a large US population-based cohort".
   Am J Ophthalmol. 2026 Oct 24:S0002-9394(26)00563.
   PubMed        
   
   
5. RUSTAM Z, Khanani AM, Mojumder O, Huddleston S, et al
   Time Course of Resolution of Diabetic Macular Edema by Sustained Suppression of VEGF-A with the Port Delivery Platform with Ranibizumab.
   Am J Ophthalmol. 2026 Oct 27:S0002-9394(26)00589.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

6. HOROZOGLU CERAN T, Beyatli S, Dogan M
   Early outcomes of switching from bevacizumab to aflibercept-jbvf in exudative macular diseases: a real-world study.
   BMC Ophthalmol. 2026;26:702.
   PubMed         Abstract available
   
   
7. TERUNA MMS, Razak TR, Yasin SM, Ali AAR, et al
   Time to diabetic retinopathy and its prognostic factors among adults with type 2 diabetes mellitus in Johor, Malaysia from 2015 to 2019: a retrospective cohort study using surveillance data.
   BMC Ophthalmol. 2026;26:701.
   PubMed         Abstract available
   
   
8. ASAD Y, Paniharam P, Goh SK, Jayakrishnan A, et al
   Comparative detection of diabetic retinopathy microvascular lesions using single-capture ultrawide-field swept-source OCT angiography versus widefield colour fundus photography.
   BMC Ophthalmol. 2026;26:680.
   PubMed         Abstract available
   
   
9. ONCUL H, Dag U, Dinc H, Alakus MF, et al
   Real-world injection burden, treatment switching, and visual outcomes in diabetic macular edema: a 563-eye cohort study.
   BMC Ophthalmol. 2026;26:676.
   PubMed         Abstract available
   
   

   
   Diabet Med

10. AKCAY N, Bingol I, Tosun D
    Fulminant non-autoimmune diabetes presenting as fatal diabetic ketoacidosis in a 2-month-old infant with genetically confirmed Wolcott-Rallison syndrome.
    Diabet Med. 2026 Oct 27:e70516. doi: 10.1111/dme.70516.
    PubMed         Abstract available
    
    
11. LORENZEN LE, Aalders J, Rasmussen B, Jensen DM, et al
    The transition from pregnancy to motherhood in women with type 2 diabetes: A longitudinal qualitative study.
    Diabet Med. 2026 Oct 27:e70513. doi: 10.1111/dme.70513.
    PubMed         Abstract available
    
    
12. COTTERILL S, Hawkes RE, Rutter MK, Elliott RA, et al
    The national implementation of 'Healthy Living', a web-based type 2 diabetes self-management education and support service: Narrative synthesis of evaluation findings and implications for service delivery and research.
    Diabet Med. 2026 Oct 25:e70494. doi: 10.1111/dme.70494.
    PubMed         Abstract available
    
    
13. ZAGHLOUL H, Elhadad S, Chagoury O, Taheri S, et al
    Examining the facilitators and barriers to health behaviour change for type 2 diabetes remission in a young population with early diabetes: A qualitative study of participants in the DIADEM-I randomised controlled trial.
    Diabet Med. 2026 Oct 27:e70514. doi: 10.1111/dme.70514.
    PubMed         Abstract available
    
    
14. EL HADIDI S, Dinneen SF, Valentelyte G, Churchill L, et al
    National clinical audits as distributed diabetes surveillance infrastructure: Consensus lessons from Ireland.
    Diabet Med. 2026 Oct 27:e70499. doi: 10.1111/dme.70499.
    PubMed         Abstract available
    
    
15. SHAH MU, Ward JK, Roebuck A, Srinivasan B, et al
    Early sodium-glucose co-transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome.
    Diabet Med. 2026 Oct 27:e70480. doi: 10.1111/dme.70480.
    PubMed         Abstract available
    
    
16. FRAZER-MORRIS C, Skachill Burke A, Nasteska D, Shilleh AH, et al
    The art of public engagement in type 1 diabetes research.
    Diabet Med. 2026 Oct 27:e70497. doi: 10.1111/dme.70497.
    PubMed         Abstract available
    
    

    
    Diabetes

17. ZENG D, Gu HF, Jing X, Tang X, et al
    CYP1B1: A Context-Dependent Regulator of Metabolism in Diabetic Kidney Disease.
    Diabetes. 2026 Oct 30:db260466. doi: 10.2337/db26-0466.
    PubMed         Abstract available
    
    
18. LIANG Y, Zhao L, Peng F, Li Q, et al
    Metadherin Drives FOXO3a Lactylation and Mitochondrial Dysfunction to Promote Podocyte Injury in Diabetic Kidney Disease.
    Diabetes. 2026 Oct 27:db260401. doi: 10.2337/db26-0401.
    PubMed         Abstract available
    
    
19. RESTE-FERREIRA D, Marques IP, Santos T, Santos AR, et al
    Different Patterns of Progression in Nonproliferative Diabetic Retinopathy: Findings From a 10-Year Cohort Study.
    Diabetes. 2026 Oct 23:db260251. doi: 10.2337/db26-0251.
    PubMed         Abstract available
    
    

    
    Diabetes Care

20. HUDSON D
    Reactions to Race[ism]: The Relationship Between Differential Treatment Based on Race and Diagnosed Diabetes Status in U.S. Adults.
    Diabetes Care. 2026 Oct 29:dci250092. doi: 10.2337/dci25-0092.
    PubMed         Abstract available
    
    
21. KLEIN KR, Pettus J, Sonnenberg GE, Akturk HK, et al
    A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Acmopatide (CT-868), a Fully Biased GLP-1/GIP Receptor Agonist, in Adults With Type 1 Diabetes and Overweight or Obesity.
    Diabetes Care. 2026 Oct 28:dc261059. doi: 10.2337/dc26-1059.
    PubMed         Abstract available
    
    
22. ADLER AI, Shine B, Snowball J, Haworth C, et al
    Long-term Glycemia and Risk of Death in Cystic Fibrosis-Related Diabetes: A UK Cystic Fibrosis Registry Study.
    Diabetes Care. 2026 Oct 26:dc261808. doi: 10.2337/dc26-1808.
    PubMed         Abstract available
    
    
23. HARBI H, Nesrallah M, Carney G, Dormuth C, et al
    Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Older Adults With Type 2 Diabetes: A Cohort Study.
    Diabetes Care. 2026 Oct 27:dc261316. doi: 10.2337/dc26-1316.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

24. BAIK SH, Baye F, Xian H, Fung KW, et al
    Neuropsychiatric Outcomes Associated With GLP-1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status.
    Diabetes Obes Metab. 2026 Oct 25. doi: 10.1111/dom.71459.
    PubMed         Abstract available
    
    
25. JUN JE, Ryu HJ, Hwang YC, Ahn KJ, et al
    Preoperative Muscle Mass and 1-Year Diabetes Remission After Metabolic Surgery: Associations Across Remission Definitions.
    Diabetes Obes Metab. 2026 Oct 25. doi: 10.1111/dom.71455.
    PubMed         Abstract available
    
    
26. SUN J, Anyalebechi J, Najafi B, Rosenthal R, et al
    Baseline Diabetes Severity Is the Dominant Predictor of Diabetes Medication Re-Initiation Following Bariatric Surgery.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71472.
    PubMed         Abstract available
    
    
27. BERKA B, Cinek O, Neuman V, Hubackova K, et al
    Population-Based Screening for Type 1 Diabetes in Czechia: Results From the First 1% of the Paediatric Population.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71463.
    PubMed         Abstract available
    
    
28. XUE B, Shen C, Ma T, Qian L, et al
    Conditional Associations of ApoB and LDL-C With Incident Type 2 Diabetes in UK Biobank: A Prospective Cohort Study.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71454.
    PubMed         Abstract available
    
    
29. NOORMANDI A, Aziz F, Madl T, Habisch H, et al
    alpha-Hydroxybutyrate and Cardiovascular Outcomes in People Living With Type 2 Diabetes: An EXSCEL Post Hoc Analysis.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71487.
    PubMed        
    
    
30. KOW CS, Zaihan AF, Ramachandram DS, Thiruchelvam K, et al
    Efficacy and Safety of CagriSema in Type 2 Diabetes: A Dose- and Comparator-Specific Systematic Review and Bayesian Meta-Analysis.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71485.
    PubMed         Abstract available
    
    
31. FAROUK L, Bashir B, Seese R, Avari P, et al
    A Comparative Analysis Between Original and Updated Glucose Management Indicator and Glycated Haemoglobin Across Continuous Glucose Monitoring Sensors in Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71484.
    PubMed         Abstract available
    
    
32. WU B, He BS
    Interpreting Diabetic Retinal Outcomes After GLP-1 Receptor Agonist and Tirzepatide Initiation: Clinical Evidence and Its Limits.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71490.
    PubMed         Abstract available
    
    
33. ROSSATTO T, de Andrade Oliveira R, Cardoso AM
    GLP-1-Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection.
    Diabetes Obes Metab. 2026 Oct 27. doi: 10.1111/dom.71428.
    PubMed         Abstract available
    
    
34. CARPENTIER L, Denimal D, Rouland A, Petit JM, et al
    Ceramides, Particularly Those Containing Very-Long-Chain Saturated Fatty Acids, Are Independently Associated With the Triglyceride-Glucose Index in European Individuals With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Oct 29. doi: 10.1111/dom.71500.
    PubMed         Abstract available
    
    
35. SU S, Liu F, Ma F, Chen S, et al
    Associations of Plasma Branched-Chain Amino Acids With Incident Atherosclerotic Cardiovascular Disease by Sex and Type 2 Diabetes Status Among Chinese Adults.
    Diabetes Obes Metab. 2026 Oct 29. doi: 10.1111/dom.71492.
    PubMed         Abstract available
    
    
36. YAMAMOTO S, Okada H, Shinozaki T, Kasahara K, et al
    Preventive Effect of Smoking Cessation on Diabetes Onset: A Target Trial Emulation Approach.
    Diabetes Obes Metab. 2026 Oct 25. doi: 10.1111/dom.71477.
    PubMed         Abstract available
    
    

    
    Diabetologia

37. BITSCH POULSEN M, Lebech Cichosz S, Julu P, Roikjer J, et al
    Preserved cardiac vagal tone is associated with nocturnal glycaemic stability.
    Diabetologia. 2026;69:3523-3532.
    PubMed         Abstract available
    
    
38. WAN J, Zhang M, Ma T, Yang Q, et al
    Hepatic PDIA5 improves hyperglycaemia and insulin resistance through stabilisation of ATF6.
    Diabetologia. 2026;69:3638-3653.
    PubMed         Abstract available
    
    
39. OLSEN MT, Spanakis EK, Thabit H, Dhatariya K, et al
    An international position statement on practical approaches for inpatient continuous glucose monitoring, insulin pumps and automated insulin delivery systems in adults.
    Diabetologia. 2026;69:3409-3424.
    PubMed         Abstract available
    
    
40. JENDLE J, Adolfsson P, Cardona-Hernandez R, Crenier L, et al
    Insulin pens and the digital ecosystem.
    Diabetologia. 2026;69:3449-3470.
    PubMed         Abstract available
    
    
41. GODINEZ LEIVA E, Barb D, Kalavalapalli S, Ortiz Rocha A, et al
    Prediabetes and diabetes as drivers of fibrosis in MASLD: roles of obesity, adipose tissue dysfunction and insulin resistance.
    Diabetologia. 2026 Oct 24. doi: 10.1007/s00125-026-06904.
    PubMed         Abstract available
    
    
42. DAVIES MJ, Aroda VR, Bajaj M, ElSayed NA, et al
    Correction: Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2026 Oct 28. doi: 10.1007/s00125-026-06911.
    PubMed        
    
    

    
    Invest Ophthalmol Vis Sci

43. ALMEIDA AC, Pais M, Pinto I, Reste-Ferreira D, et al
    Retinal Microvascular and Neuronal Alterations in Type 2 Diabetes: Insights From a Population-Based Screening Program (START2).
    Invest Ophthalmol Vis Sci. 2026;67:61.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

44. KLEMETTI MM, Li J, Alahari S, Pettersson ABV, et al
    Lipidomes of placenta-derived extracellular vesicles reveal disrupted metabolic adaptation in type 1 diabetes.
    J Clin Endocrinol Metab. 2026 Oct 30:dgag411. doi: 10.1210.
    PubMed         Abstract available
    
    
45. LIU Q, Mayer DFR, Harding JE, Gamble GD, et al
    Short and long-term outcomes after gestational diabetes diagnosis using different glycemic criteria: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2026 Oct 30:dgag448. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

46. SARKAR A, Dhar S, Bera S, Chakravarti M, et al
    Experimental high blood glucose metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis.
    J Immunol. 2026;215:vkag262.
    PubMed         Abstract available
    
    

    
    JAMA

47. BISWAS S, Srivastava Y, Jadvani D
    Orforglipron for Type 2 Diabetes and Pancreatic Risk Assessment.
    JAMA. 2026 Oct 26. doi: 10.1001/jama.2026.18104.
    PubMed        
    
    
48. GIORGINO F, Ludwig L, Denning M
    Orforglipron for Type 2 Diabetes and Pancreatic Risk Assessment-Reply.
    JAMA. 2026 Oct 26. doi: 10.1001/jama.2026.18107.
    PubMed        
    
    

    
    Metabolism

49. LI Y, Zhou P, Zhang E
    Oxidative balance metabolite signatures in PREDIMED: Interpreting the divergent cardiovascular and diabetes findings.
    Metabolism. 2026 Oct 30:156814. doi: 10.1016/j.metabol.2026.156814.
    PubMed        
    
    

    
    Ophthalmology

50. KIM SJ
    Preventing Diabetic Retinopathy with Systemic Interleukin-6 Inhibition: Do Not Hold Your Breath Just Yet.
    Ophthalmology. 2026 Oct 26:S0161-6420(26)00750.
    PubMed        
    
    

    
    PLoS Genet

51. DINH BL, Wang X, Sheng X, Wan P, et al
    Meta-analysis of over 8,000 individuals from Hawai'i and Samoa for genetic associations to cardiometabolic phenotypes.
    PLoS Genet. 2026;22:e1012342.
    PubMed         Abstract available
    
    

    
    PLoS One

52. SCHWARTZ MD, Hu J, Sherman SE, Gore R, et al
    Community health worker intervention to prevent incident type 2 diabetes: A cluster randomized trial.
    PLoS One. 2026;21:e0361464.
    PubMed         Abstract available
    
    
53. KHAN F, Jamil Y, Wajid R, Khan A, et al
    Harnessing chia seed polysaccharides for green synthesis of copper-based nanoparticles with antidiabetic and anti-inflammatory activities.
    PLoS One. 2026;21:e0361692.
    PubMed         Abstract available
    
    
54. SIMSEKOGLU N, Arslanoglu I, Portakal B, Aktas S, et al
    Eating behaviour and glycaemic control: A cross-sectional study in adolescents with diabetes.
    PLoS One. 2026;21:e0361574.
    PubMed         Abstract available
    
    
55. BONILLA-ESCOBAR FJ, Atta S, Eibel MR, Wesalo JS, et al
    Factors associated with loss to follow-up after point-of-care diabetic retinopathy examination in a teleophthalmology program: A retrospective cohort study.
    PLoS One. 2026;21:e0359305.
    PubMed         Abstract available
    
    
56. CHENG Y, Jia L, Sheng L, Han X, et al
    TRPM7 modulates endothelial cell functions and VEGFA-associated signaling in diabetic foot.
    PLoS One. 2026;21:e0359834.
    PubMed         Abstract available
    
    
57. ALVIZ LF, Oyola JD, Martinez-Lemus JD, Perez-Lopez JA, et al
    Stroke knowledge and intended care-seeking behavior among adults with hypertension and type 2 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0335001.
    PubMed         Abstract available
    
    
58. RAFIEIAN M, Farbu EH, Hoper AC, Valtonen R, et al
    Heart rate and blood pressure variability, and baroreflex sensitivity, during heat exposure in persons with type 2 diabetes and hypertension.
    PLoS One. 2026;21:e0361367.
    PubMed         Abstract available
    
    
59. HUANG S, Li Y
    Cross-platform comparison of diabetic foot ulcer transcriptomes identifies partially concordant disease-associated signals.
    PLoS One. 2026;21:e0356328.
    PubMed         Abstract available
    
    
60. KOBAYASHI F, Tamura Y, Murao Y, Toyoshima K, et al
    Depressive symptoms are associated with the incidence of frailty in older adults with cardiometabolic diseases: Interaction between depression and diabetes.
    PLoS One. 2026;21:e0360802.
    PubMed         Abstract available
    
    
61. DOWNIE CG, Highland HM, Howard AG, Alotaibi M, et al
    Evaluating associations of oxylipin metabolites and fatty acids with incident and prevalent type 2 diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    PLoS One. 2026;21:e0360656.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. OMAR-HMEADI M, Matuseviciene L, Liu L, Lund PE, et al
    Pancreatic delta cells are resistant to auto- and paracrine inhibition in human type-2 diabetes.
    Proc Natl Acad Sci U S A. 2026;123:e2601168123.
    PubMed         Abstract available
    
    

    
    Retina

63. VUJOSEVIC S, Toma C, Cipponeri E, Piccoli G, et al
    Clinical assessment and relationship of retinal fluorophores and microvascular modifications in early diabetic retinal disease in type 1 diabetes.
    Retina. 2026 Oct 27. doi: 10.1097/IAE.0000000000005039.
    PubMed         Abstract available
    
    
64. HUANG D, Ren L, Lv L, Yi J, et al
    Regional and Temporal Changes in Choroidal Vascularity after Panretinal Photocoagulation in Diabetic Retinopathy: A Widefield SS-OCTA Study.
    Retina. 2026 Oct 27. doi: 10.1097/IAE.0000000000005037.
    PubMed         Abstract available
    
    

    
    Transplant Proc

65. HOVEN A, Toftum ST, Hovd M, Asberg A, et al
    Sodium-Glucose Cotransporter-2 Inhibitor Use in Kidney Transplant Recipients With Post-Transplantation Diabetes Mellitus - A Cross-Sectional Study.
    Transplant Proc. 2026 Oct 24:S0041-1345(26)00518.
    PubMed         Abstract available
    
    

    
    Transplantation

66. BLAZQUEZ-BERMEJO Z, Enriquez-Vazquez D, Garcia-Romero E, Mitroi C, et al
    Glucagon-like Peptide-1 Receptor Agonists in Heart Transplant Recipients With Type 2 Diabetes: A Multicenter Study.
    Transplantation. 2026 Oct 27. doi: 10.1097/TP.0000000000005945.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum